CN1644206A - 含有生物碱盐的治癣药物及其制备工艺 - Google Patents
含有生物碱盐的治癣药物及其制备工艺 Download PDFInfo
- Publication number
- CN1644206A CN1644206A CN 200410015265 CN200410015265A CN1644206A CN 1644206 A CN1644206 A CN 1644206A CN 200410015265 CN200410015265 CN 200410015265 CN 200410015265 A CN200410015265 A CN 200410015265A CN 1644206 A CN1644206 A CN 1644206A
- Authority
- CN
- China
- Prior art keywords
- grams
- chinese medicine
- fructus
- medicinal liquid
- medicine filter
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 52
- 238000002360 preparation method Methods 0.000 title claims description 11
- 208000002474 Tinea Diseases 0.000 title abstract description 30
- 241000130764 Tinea Species 0.000 title abstract description 21
- 229940079593 drug Drugs 0.000 title description 12
- 159000000011 group IA salts Chemical class 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000007788 liquid Substances 0.000 claims abstract description 25
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims abstract description 24
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229930013930 alkaloid Natural products 0.000 claims abstract description 12
- 239000005711 Benzoic acid Substances 0.000 claims abstract description 11
- 235000010233 benzoic acid Nutrition 0.000 claims abstract description 11
- -1 alkaloid salt Chemical class 0.000 claims abstract description 10
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229960004889 salicylic acid Drugs 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 10
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229930003836 cresol Natural products 0.000 claims abstract description 9
- 238000007789 sealing Methods 0.000 claims abstract description 9
- 239000006228 supernatant Substances 0.000 claims abstract description 9
- 238000001914 filtration Methods 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 16
- 238000005516 engineering process Methods 0.000 claims description 9
- 241001116389 Aloe Species 0.000 claims description 8
- 235000017858 Laurus nobilis Nutrition 0.000 claims description 8
- 241000131808 Scolopendra Species 0.000 claims description 8
- 241000522620 Scorpio Species 0.000 claims description 8
- 244000125380 Terminalia tomentosa Species 0.000 claims description 8
- 235000005212 Terminalia tomentosa Nutrition 0.000 claims description 8
- 235000011399 aloe vera Nutrition 0.000 claims description 8
- 239000009670 cang er zi wan Substances 0.000 claims description 8
- 150000002576 ketones Chemical class 0.000 claims description 8
- 229910052757 nitrogen Inorganic materials 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 239000009490 scorpio Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 230000003203 everyday effect Effects 0.000 claims description 6
- 239000008155 medical solution Substances 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 21
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- MUKYLHIZBOASDM-UHFFFAOYSA-N 2-[carbamimidoyl(methyl)amino]acetic acid 2,3,4,5,6-pentahydroxyhexanoic acid Chemical compound NC(=N)N(C)CC(O)=O.OCC(O)C(O)C(O)C(O)C(O)=O MUKYLHIZBOASDM-UHFFFAOYSA-N 0.000 abstract 1
- DPPKHDNNSNHRRD-UHFFFAOYSA-N 3-dodecylazepin-2-one Chemical compound C(CCCCCCCCCCC)C=1C(N=CC=CC1)=O DPPKHDNNSNHRRD-UHFFFAOYSA-N 0.000 abstract 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 241000819233 Tribulus <sea snail> Species 0.000 abstract 1
- 241001233305 Xanthisma Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 1
- 229960000278 theophylline Drugs 0.000 abstract 1
- 229940047183 tribulus Drugs 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 16
- 238000012360 testing method Methods 0.000 description 9
- 239000003440 toxic substance Substances 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 241000893966 Trichophyton verrucosum Species 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 201000004647 tinea pedis Diseases 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 206010005913 Body tinea Diseases 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 description 3
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 229930014456 matrine Natural products 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 229940098465 tincture Drugs 0.000 description 3
- 201000003875 tinea corporis Diseases 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 208000007712 Tinea Versicolor Diseases 0.000 description 2
- 201000010618 Tinea cruris Diseases 0.000 description 2
- 206010067197 Tinea manuum Diseases 0.000 description 2
- 206010056131 Tinea versicolour Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 230000003385 bacteriostatic effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000001338 necrotic effect Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 229960001860 salicylate Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 201000009862 superficial mycosis Diseases 0.000 description 2
- 231100000027 toxicology Toxicity 0.000 description 2
- 238000012795 verification Methods 0.000 description 2
- 241000222122 Candida albicans Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012504 Dermatophytosis Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241001460074 Microsporum distortum Species 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 241000893976 Nannizzia gypsea Species 0.000 description 1
- RBBVPNQTBKHOEQ-KKSFZXQISA-O Phellodendrine Chemical compound C1CC2=CC(OC)=C(O)C=C2[C@H]2[N@+]1(C)CC(C=C(C(=C1)O)OC)=C1C2 RBBVPNQTBKHOEQ-KKSFZXQISA-O 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241000223238 Trichophyton Species 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013064 chemical raw material Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 210000003780 hair follicle Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 210000004906 toe nail Anatomy 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Abstract
Description
病种 | 例数 | 痊愈 | 显效 | 有效 | 无效 | 有效率 |
手足癣 | 52 | 28(53.85%) | 7(13.46%) | 13(25.00%) | 4(7.69%) | 92.31% |
股 癣 | 24 | 15(62.50%) | 4(16.67%) | 4(16.67%) | 1(4.16%) | 95.83% |
体 癣 | 13 | 9(69.23%) | 2(15.38%) | 2(15.38%) | 0 | 100% |
花斑癣 | 11 | 8(72.72%) | 2(18.18%) | 1(9.09%) | 0 | 100% |
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100152655A CN100344310C (zh) | 2004-01-19 | 2004-01-19 | 含有生物碱盐的治癣药物及其制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2004100152655A CN100344310C (zh) | 2004-01-19 | 2004-01-19 | 含有生物碱盐的治癣药物及其制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1644206A true CN1644206A (zh) | 2005-07-27 |
CN100344310C CN100344310C (zh) | 2007-10-24 |
Family
ID=34867989
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004100152655A Expired - Lifetime CN100344310C (zh) | 2004-01-19 | 2004-01-19 | 含有生物碱盐的治癣药物及其制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100344310C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101972408A (zh) * | 2010-10-19 | 2011-02-16 | 赵自裕 | 一种癣洗净中药制剂及其配制方法 |
CN102362844A (zh) * | 2011-11-07 | 2012-02-29 | 金华职业技术学院 | 芳香型植物抑菌护肤洗脚液及其制备方法 |
CN102552522A (zh) * | 2011-12-15 | 2012-07-11 | 李秀香 | 一种治疗头皮屑的中药组合物 |
CN104225023A (zh) * | 2013-06-13 | 2014-12-24 | 香港浸会大学 | 包含黄连、黄柏以及栀子并且用于治疗神经变性疾病的组合物 |
CN104971125A (zh) * | 2014-04-14 | 2015-10-14 | 黄冠华 | 一种治疗银屑病的生物碱盐类药物及其制备工艺 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1151811C (zh) * | 2001-01-04 | 2004-06-02 | 黄兆元 | 三七复方止痛合剂 |
-
2004
- 2004-01-19 CN CNB2004100152655A patent/CN100344310C/zh not_active Expired - Lifetime
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101972408A (zh) * | 2010-10-19 | 2011-02-16 | 赵自裕 | 一种癣洗净中药制剂及其配制方法 |
CN102362844A (zh) * | 2011-11-07 | 2012-02-29 | 金华职业技术学院 | 芳香型植物抑菌护肤洗脚液及其制备方法 |
CN102362844B (zh) * | 2011-11-07 | 2013-12-11 | 金华职业技术学院 | 芳香型植物抑菌护肤洗脚液及其制备方法 |
CN102552522A (zh) * | 2011-12-15 | 2012-07-11 | 李秀香 | 一种治疗头皮屑的中药组合物 |
CN104225023A (zh) * | 2013-06-13 | 2014-12-24 | 香港浸会大学 | 包含黄连、黄柏以及栀子并且用于治疗神经变性疾病的组合物 |
US9375457B2 (en) | 2013-06-13 | 2016-06-28 | Hong Kong Baptist University | Composition comprising Rhizoma coptidis, Cortex phellodendri and Fructus gardeniae and for treating neurodegenerative diseases |
CN104971125A (zh) * | 2014-04-14 | 2015-10-14 | 黄冠华 | 一种治疗银屑病的生物碱盐类药物及其制备工艺 |
Also Published As
Publication number | Publication date |
---|---|
CN100344310C (zh) | 2007-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101062343A (zh) | 一种用于治疗皮肤瘤、癣、疣、疱疹的外用中药 | |
CN102228479A (zh) | 一种治疗口腔疾病的药物及其制备方法 | |
Taiwo et al. | Consumption of aqueous extract of raw Aloe vera leaves: histopathological and biochemical studies in rat and tilapia | |
CN100344310C (zh) | 含有生物碱盐的治癣药物及其制备工艺 | |
CN102100735B (zh) | 一种治疗真菌性皮肤病的药物组合物 | |
CN1092981C (zh) | 治疗由风寒湿所致痹症的药物及其制备方法 | |
CN108498535A (zh) | 一种用于治疗皮肤及黏膜感染的聚维酮碘药物组合物及其制备方法和应用 | |
CN1251738C (zh) | 一种治疗灰指甲的中药及其制备方法 | |
CN1846737A (zh) | 一种治疗心脑血管疾病的药物及其制作方法 | |
CN101934032A (zh) | 一种治疗糖尿病的中药复方外用制剂及其制备方法和应用 | |
CN101040957A (zh) | 治疗湿疹及皮炎类皮肤病的药物及其制备方法 | |
CN1660353A (zh) | 一种治疗宫颈炎、阴道炎的中药凝胶剂及其制备方法 | |
CN1213750C (zh) | 岩白菜素在制备治疗前列腺增生的药物中的应用 | |
CN101053612A (zh) | 妇科外用的中药洁阴剂及其洁阴凝膏 | |
CN1178669A (zh) | 含大黄酸的治疗糖尿病肾病的药 | |
CN1613463A (zh) | 一种外用治疗关节疼痛的中药组合物贴膏 | |
CN1259905C (zh) | 姜黄素在制备治疗肺病的药物中的用途 | |
CN1883620A (zh) | 一种治疗浅部真菌感染的凝胶剂及其制备方法 | |
CN1293893C (zh) | 一种治疗宫颈炎、宫颈糜烂、阴道炎的中药凝胶剂及其制备方法 | |
CN101632725A (zh) | 止痒消肿液 | |
CN1208069C (zh) | 一种治疗皮肤病药液的配制方法 | |
CN1067895C (zh) | 治疗手、足癣的中西药制剂及其制备方法 | |
CN1244398A (zh) | 中、西药结合治疗皮肤真菌病症的改进型酊剂 | |
CN1236809C (zh) | 一种治疗外伤的药物及其制备方法 | |
CN1063632C (zh) | 一种治疗皮肤病的外用搽剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Shenzhen Huangguan pharmaceutical science and Technology Co.,Ltd. Assignor: Huang Zaotang Contract record no.: 2011440020407 Denomination of invention: Medicine for treating tinea containing biological alkaline salt and preparation thereof Granted publication date: 20071024 License type: Exclusive License Open date: 20050727 Record date: 20111123 |
|
PP01 | Preservation of patent right |
Effective date of registration: 20190509 Granted publication date: 20071024 |
|
PP01 | Preservation of patent right | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20220509 Granted publication date: 20071024 |
|
PD01 | Discharge of preservation of patent | ||
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20071024 |